Cannabis use disorders part II: Psychiatric and somatic sequelae and comorbidities;Cannabisbezogene störungen teil II: psychiatrische und somatische folgestörungen und komorbiditäten

Fortschritte der Neurologie Psychiatrie

Volumn 78, Issue 6, 2010, Pages 360-370

  Bonnet, U ^a   Scherbaum, N ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

CANNABIS ADDICTION; COMORBIDITY; HUMAN; INTOXICATION; REVIEW;

EID: 77953161832     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0029-1245173     Document Type: Review

References (48)

1. Bonnet U, Scherbaum N. Evidenzbasierte Behandlung der Cannabisabhängigkeit. In: Backmund M (Hrsg). Suchttherapie Landsberg Ecomed 2007 Kap. IX 3 1-28
2. Dannon P N., Lowengrup K, Amiaz R et al. Comorbid cannabis use and panic disorder: short term and long term follow-up. Hum Psychopharmacology 2004 19 97-101
3. Johns A. Psychiatric effects of cannabis. British J Psychiatr 2001 178 116-122
4. Degenhardt L, Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 2001 96 1603-1614
5. Bonnet U, Harries-Hedder K, Leweke F M. et al. AWMF-Leitlinie: Cannabis-bezogene In: LG Schmidt, M Gastpar, P Falkai, et al (Hrsg) Evidenzbasierte Suchtmedizin Köln Deutscher ärzte-Verlag 2006 143-170
6. Budney A J., Hughes J R., Moore B A. et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 2004 161 1967-1977
7. Budney A J., Vandrey R G., Hughes J R. et al. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. JSubstance Abuse treat 2008 35 362-368
8. Cornelius J R., Chung T, Martin C et al. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav 2008 33 1500-1505
9. Benyamina A, Lecacheux M, Blecha L et al. Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. Expert Rev Neurother 2008 8 479-491
10. Nunez L A., Gurpegui M. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. Acta Psychiatr Scand 2002 105 173-178
11. Leweke F M., Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol 2008 13 264-275
12. Gaillard M C., Borruat F X. Persisting visual hallucinations and illusions in previosly drug-addicted patients. Klin Montsbl Augenheilk 2003 220 176-178
13. Täschner K L. Cannabis. Biologie, Konsum und Wirkung. Köln Deutscher ärzte-Verlag 2005
14. Pope H G., Gruber A J., Hudson J I. et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001 56 909-915
15. Grant I Jr, Gonzales R, Carey C L. et al. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. Journal of the International Neuropsychological Society 2003 9 679-689
16. Solowji N, Roffman R A., Barbor T et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002 287 1123-1131
17. Fried P A. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. Canadian Medical Association Journal 2002 166 887-891
18. Bolla K I. Dose related neurocognitive effects of marijuana use. Neurology 2002 59 1337-1343
19. Pope jr H G., Gruber A J., Hudson J I. et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 2003 69 303-310
20. Petersen K U., Thomasius R. Auswirkungen von Cannabiskonsum und -missbrauch. Eine Expertise zu gesundheitlichen und psychosozialen Folgen. Ein systematisches Review der international publizierten Studien von 1996 2006. Lengerich Pabst-Verlag 2007
21. Kendler K S., Prescott C A. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 1998 155 1016-1022
22. Kandel D, Chen K. Types of marihuana users by longitudinal course. JStud Alcohol 2000 61 367-378
23. Henquet C, Krabbendam L, Graaf R de et al. Cannabis use and expression of mania in the general population. JAffect Disord 2006 95 103-10
24. Harder V S., Morral A R., Arkes J. Marijuana use and depression among adults: testing for causal associations. Addiction 2006 101 1463-1472
25. Watzke A B., Schmidt C O., Zimmermann J et al. Personality disorders in a clinical sample of cannabis dependent young adults. Fortschr Neurol Psychiatr 2008 76 600-605
26. Tournier M, Sorbara F, Gindre C et al. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res 2003 118 1-8
27. Green A I., Burgess E S., Dawson R et al. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr res 2003 60 81-85
28. Stuyt E B., Sajbel T A., Allen M H. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. Am J Addict 2006 15 166-173
29. Potvin S, Stip E, Lipp O et al. Quetiapine in patients with comorbid schizophrenia-spectrum and substance disorders: an open-label trial. Curr Med Res Opin 2006 22 1277-1285
30. Van Nimwegen L J., Haan L de, Beberen N J. et al. Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. Can J Psychiatry 2008 53 400-405
31. Edwards J van, Elkins K, Hinton M et al. Randomized controlled trial of a cannabis-focused intervention for people with first-episode psychosis. Acta Psychiatr Scand 2006 114 109-117
32. Bellack A s, Bennett M E., Gearon J S. et al. A randomized clinical trial of a behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006 63 426-432
33. Sigmon S C., Higgins S T. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. JSubst Abuse Treat 2006 30 291-295
34. Fergusson D M., Horwood J. Does cannabis use encourage other forms of illicit drug use? Addiction 2000 95 505-520
35. Simon R, Sonntag D, Bühringer G et al. Cannabisbezogene Störungen: Umfang, Behandlungsbedarf und Behandlungsangebot in Deutschland. München IFT 2004
36. Jones R T. Cardiovascular system effects of marijuana. JClin Pharmacol 2002 42 (11 Suppl) 58S-63S
37. Peyrot I, Garsaud A M., Saint-Cyr I et al. Cannabis arteriitis: a new case report and a review of literature. JEur Acad Dermatol Venereol 2007 21 388-391
38. Wargo K A., Geveden B, McConnell V J. Cannabinoid-induced pancreatitis: a case series. JOP 2007 (online) 8 579-583
39. Boratyrewicz M, Urasinska E, Rozanski J et al. Membranous glomerulonephritis may be associated with heavy marijuana abuse. Transplant Proc 2007 39 3054-3056
40. Schwartz R H. Marijuana: a decade and a half later, still a crude drug with underappreciated toxicity. Pediatrics 2002 109 284-289
41. Allen J H., Moore G M., Twartz J C. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004 53 1566-1570
42. Hezode C de, Zafrani E S., Roudot-Thoraval F et al. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C? Gastroenterology 2008 134 432-439
43. Weintrieb R M., Lucey M R. Treatment of addictive behaviors in liver transplant patients. Liver Transplantation 2007 13 (Suppl 2) S79-S82
44. Taylor D R., Fergusson D M., Milne B J. et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002 97 1055-1061
45. Fried P A., Smith A M. A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001 23 1-11
46. Busse F P., Fiedler G M., Leichtle A et al. Bleiintoxikationen durch gestrecktes Marihuana in Leipzig. Deutsches ärzteblatt 2008 105 757-62
47. Brandenburg D, Wernick R. Intraveneous marijuana syndrome. West J Med 1986 145 94-96
48. Robson P. Human studies of cannabinoids and medical cannabis. Handb Exp Pharmacol 2005 168 719-756